About Us

Moving Mountains for Multiple Myeloma (MM4MM) is collaboration between CURE Media Group and the Multiple Myeloma Research Foundation (MMRF) to raise awareness and funds for myeloma research. In 2018, Amgen and Celgene Corporation have joined the effort as sponsors.

Patients, caregivers, myeloma doctors and nurses and myeloma loved ones take on challenging mountains — Mount Kilimanjaro, the Grand Canyon, Peru’s Machu Picchu, Mt. Fuji and Everest Base Camp — to demonstrate that the advancements being made in recent years, funded and spearheaded by the MMRF, are helping patients live longer with a higher quality of life than ever before.

The first climb, in January 2016, saw a team of 15 MMRF supporters, which included four myeloma patients and a myeloma doctor, climb Mount Kilimanjaro, the highest free standing mountain in the world. This team raised close to $250,000, with all proceeds going to the MMRF to fuel its groundbreaking precision medicine model, which focuses on bringing the right treatment to the right patient at the right time.

Since that time, seven additional climbs have taken place. In May 2016, 13 hikers took on the Bright Angel Trail in the Southern Rim of the Grand Canyon. In August 2016, a team of 20 hiked the Inca Trail to Machu Picchu. Second expeditions to Mount Kilimanjaro and the Grand Canyon took place in 2017, one in February and the other in May. In July of 2017, a team of took on Japan’s tallest and most iconic mountain, Mt. Fuji. In March 2018, a group of 18 took on the most epic adventure of all: a 9-day journey through the Himalayan Mountains to the Everest Base Camp. Our most recent trek, which took place in May of 2018, saw 15 team members hike deep into the Grand Canyon’s majestic Havasupi region.

To date, the Moving Mountains for Multiple Myeloma program has raised more than $1.7 million, all of which goes directly to the MMRF. All told, the program has engaged a total of 151 supporters including 41 multiple myeloma patients, eight myeloma doctors, five myeloma clinical trial managers, three nurses and other family members of patients, living or deceased. Also, included on each climb is a representative from our pharma partners, CURE Media, and the MMRF.

"There is nothing more powerful than working together with multiple myeloma patients, doctors and nurses, caregivers and partners like Amgen, Celgene and CURE toward a common goal," says Alicia O’Neill, a climber for the MM4MM program and an MMRF executive. "Pushing beyond perceived limits, working together with our dedicated partners, we are demonstrating that together, with our partners we are going to the ends of the earth and the top of the world to accelerate research and find cures for multiple myeloma.

"When those touched by myeloma see patients taking on these incredible feats, we hope that they are inspired, states Marty Murphy. While not every patient can dream of summiting the 19,341-foot peak in Africa, we hope our efforts and accomplishments serve as inspiration. Patient climbers can demonstrate that there is hope and progress. Yet we can’t stop until there is a cure.

Kilimanjaro climber and multiple myeloma patient Bod Dickey of Shell Beach, California, says, "For me, Mount Kilimanjaro was validation that multiple myeloma is not the end. The climb illustrates to patients and caregivers that multiple myeloma offers us an opportunity, if not a requirement, to press harder.

Amgen and Celgene are proud supporters of the Moving Mountains for Multiple Myeloma Program in 2018.

Interested in multiple myeloma updates from CURE®? Sign up for our newsletter!

Multiple Myeloma Research Foundation

View our interviews with climber Chuck Wakefield
Terms & Conditions | Privacy Policy